Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

Publication Date

2024

Content Type

Article

PubMed ID:

38485190

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS